Table II.
Brain Distribution and Efflux Transporter Liability of some Molecular-targeted Therapeutic Agents for the Treatment of Brain Tumors
| Molecular target | Compound | Species | Kp | fu,plasma | fu,brain | Kp,uu | P-gp substrate | BCRP substrate | Ref. |
|---|---|---|---|---|---|---|---|---|---|
| DNA alkylation | TMZ | mouse | 0.56 | NR | NR | NR | Yes | Yes | [99] |
| ATR | Berzosertib | mouse | 0.64 | 0.081 | 0.0014 | 0.011 | Yes | Yes | [73] |
| ATM | AZD1390 | mouse | 0.29 | 0.203 | 0.075 | 0.1 | Yes | No | [100] |
| ATM | AZD1390 | mouse | NR | NR | NR | 0.04 | Yes or no# | Yes or no# | [50] |
| ATM | AZD1390 | Cynomolgus monkey | 5.8* | 0.175 | 0.01 | 0.33 | NR | NR | [50] |
| ATM | WSD-0628 | mouse | NR | 0.0285 | 0.0269 | 0.3 | No | No | [101] |
| DNA-PK | Peposertib | mouse | 0.09 | 0.114 | 0.041 | 0.03 | Yes | Yes | [49] |
| PARP | Pamiparib | rat | 0.18 | NR | NR | 0.158 | No | No | [102] |
| p53/MDM2 | SAR405838 | mouse | 0.0275 | 0.00059 | 0.00015 | 0.007 | Yes | No | [103] |
| p53/MDM2 | BI-907828 | mouse | 0.009 | 0.0015 | 0.0003 | 0.002 | Yes | No | [104] |
| EGFR | AEE788 | mouse | 0.066 | 0.068 | 0.029 | 0.029 | Yes or no# | Yes or no# | [105] |
| EGFR | Afatinib | mouse | 0.254 | 0.08 | 0.014 | 0.046 | Yes | Yes | [105] |
| EGFR | AZD3759 | mouse | 1.7 | 0.058 | 0.101 | 2.96 | No | No | [105] |
| EGFR | Dacomitinib | mouse | 0.612 | 0.008 | 0.007 | 0.493 | Yes or no# | Yes or no# | [105] |
| EGFR | Erlotinib | mouse | 0.062 | 0.045 | 0.096 | 0.134 | Yes | Yes | [105] |
| EGFR | Gefitinib | mouse | 0.358 | 0.041 | 0.012 | 0.103 | Yes | Yes | [105] |
| EGFR | Osimertinib | mouse | 0.988 | 0.005 | 0.001 | 0.289 | Yes | Yes | [105] |
| EGFR | Vandetanib | mouse | 0.635 | 0.055 | 0.012 | 0.138 | Yes | Yes | [105] |
| PDGFR-α | Ponatinib | mouse | 0.82 | 0.0023 | 0.0003 | 0.11 | Yes | Yes | [106] |
| PI3K | GNE-317 | mouse | 1.1 | NR | NR | 0.398 | NR | NR | [107] |
| PI3K | Pictilisib | mouse | 0.0127 | NR | NR | 0.0035 | Yes | Yes | [107] |
| PI3K | GDC-0084 | mouse | 1.37 | 0.29 | 0.067 | 0.41 | No | No | [108] |
| panRAF | CCT196969 | mouse | 0.006 | 0.001 | 0.005 | 0.03 | Yes or no# | Yes or no# | [109] |
| panRAF | LY3009120 | mouse | 0.05 | 0.0182 | 0.0093 | 0.02 | Yes or no# | Yes or no# | [109] |
| panRAF | MLN2480 | mouse | 0.2 | 0.0421 | 0.0098 | 0.05 | Yes or no# | Yes or no# | [109] |
| MEK | E6201 | mouse | 2.66 | 0.026 | 0.0014 | 0.14 | No | No | [75] |
| MEK | Trametinib | mouse | 0.15 | 0.0021 | 0.0021 | 0.15 | Yes or no# | Yes or no# | [75] |
| MEK | Cobimetinib | mouse | 0.32 | 0.014 | 0.0012 | 0.027 | Yes or no# | Yes or no# | [75] |
| KIF11 | Ispinesib | mouse | 0.23 | 0.06 | 0.005 | 0.02 | Yes | Yes | |
| Aurora A kinase | Alisertib | mouse | 0.03 | 0.042 | 0.063 | 0.0044 | Yes | No | [110] |
| CDK4/6 | Abemaciclib | mouse | 1.2 | 0.054 | 0.0079 | 0.17 | Yes | Yes | [111] |
| CDK4/6 | Palbociclib | mouse | 0.1 | 0.23 | 0.02 | 0.01 | Yes | Yes | [111] |
yielded by PET data
substrate of P-gp and/or BCRP; NR, not reported
Kp: drug partition coefficient in the brain; fu,plasma: drug unbound fraction in plasma; fu,brain: drug unbound fraction in brain; Kp,uu: unbound drug partition coefficient in the brain